However, it wasnot used for preventing re-bleeding.CONCLUSION: To prevent the development of this complication (SIADH), the use of desmopressin, an analogue of vasopressin,is important in routine clinical practice.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:AIM: To discuss the management of patients with the syndrome of inappropriate antidiuretic hormone secretion (SIADH) developingafter subarachnoid hemorrhage, in a comparative manner in the light of the literature.MATERIAL and METHODS: Without country or language restrictions, articles with high evidential value found in electronicdatabases were compared to our patients’ data.RESULTS: After the literature review, three articles were included for systematic evaluation.
📊
Key Findings & Data:Desmopressin was administered to thepatients for the treatment of hyponatremia, volume contraction, and negative sodium balance caused by SIADH.
💡
Conclusion & Impact:However, it wasnot used for preventing re-bleeding.CONCLUSION: To prevent the development of this complication (SIADH), the use of desmopressin, an analogue of vasopressin,is important in routine clinical practice.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
AIM: To discuss the management of patients with the syndrome of inappropriate antidiuretic hormone secretion (SIADH) developingafter subarachnoid hemorrhage, in a comparative manner in the light of the literature.MATERIAL and METHODS: Without country or language restrictions, articles with high evidential value found in electronicdatabases were compared to our patients’ data.RESULTS: After the literature review, three articles were included for systematic evaluation. Desmopressin was administered to thepatients for the treatment of hyponatremia, volume contraction, and negative sodium balance caused by SIADH. However, it wasnot used for preventing re-bleeding.CONCLUSION: To prevent the development of this complication (SIADH), the use of desmopressin, an analogue of vasopressin,is important in routine clinical practice.
🔖
Cite This Article
KARAARSLAN, N., YILMAZ, İ., AKGUN, F. S., ÇALIŞKAN, T., ÖZBEK, H., ATES, O. (2020). Systematic Evaluation of Desmopressin Administered to Patients with Aneurysmal Subarachnoid Hemorrhage in the Light of the Literature. Turkish Neurosurgery, Cilt: 30 - Sayı: 6, 787–792. https://ajindex.com/articles/405262
Akgun FS, Karaarslan N, Yilmaz I, Ozbek H, Caliskan T, Ates O: Systematic evaluation of adverse reactions that may occur after injection of type-A botulinum toxin in patients with spasmodic torticollis admitted to emergency department. Merit Res J Med Med Sci 6: 68-72, 2018 2. Boldt C, Röschel T, Himmerkus N, Plain A, Bleich M, Labes R, Blum M, Krause H, Magheli A, Giesecke T, Mutig K, Rothe M, Weldon SM, Dragun D, Schunck WH, Bachmann S, Paliege A: Vasopressin lowers renal epoxyeicosatrienoic acid levels by activating soluble epoxide hydrolase. Am J Physiol Renal Physiol 311: 1198-1210, 2016 3. Chen SL, Huang YH, Hung TW, Ou YC: Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice. Int J Clin Pract 70: 372-379, 2016 4. Cort JH: Cerebral salt wasting. Lancet 10: 752-754, 1954 5. Crowley RW, Dumont AS: Hyponatremia and cerebral vasospasm following subarachnoid hemorrhage. Neurol India 54: 247, 248, 2016 6. Diringer MN, Zazulia AR: Aneurysmal subarachnoid hemorrhage: Strategies for preventing vasospasm in the intensive care unit. Semin Respir Crit Care Med 38: 760-767, 2017 7. Dóczi T, Szerdahelyi P, Gulya K, Kiss J: Brain water accumulation after the central administration of vasopressin. Neurosurgery 11: 402-407, 1982 8. Francoeur CL, Roh D, Schmidt JM, Mayer SA, Falo MC, Agarwal S, Connolly ES, Claassen J, Elkind MSV, Park S: Desmopressin administration and rebleeding in subarachnoid hemorrhage: Analysis of an observational prospective database. J Neurosurg 2018 (Epub Ahead of Print) 9. Frontera JA, Lewin JJ 3rd, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, del Zoppo GJ, Kumar MA, Peerschke EI, Stiefel MF, Teitelbaum JS, Wartenberg KE, Zerfoss CL: Guideline for reversal of antithrombotics in intracranial hemorrhage: A statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care 24: 6-46, 2016 10. Ibrahim GM, Macdonald RL: Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 43: 2102-2107, 2012 11. Inagawa T: Risk factors for cerebral vasospasm following aneurysmal subarachnoid hemorrhage: A review of the literature. World Neurosurg 85: 56-76, 2016 12. Jovanovic V, Pekic S, Stojanovic M, Tasic G, Djurovic B, Soldatovic I, Doknic M, Miljic D, Djurovic M, Medic-Stojanoska M, Popovic V: Neuroendocrine dysfunction in patients recovering from subarachnoid